Plunkett Research Online: Adhera Therapeutics Inc

ADHERA THERAPEUTICS INC (ATRX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adhera Therapeutics, Inc. (formerly Marina Biotech, Inc.) is an emerging specialty pharmaceutical company focused on fixed dose combination (FDC) therapies in hypertension, with plans to expand the portfolio of drugs it commercializes to include other therapeutic areas. Adhera’s current product is .....


ADHERA THERAPEUTICS INC

Ticker: ATRX
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 919-578-5901
Fax:
Address: 4721 Emperor Blvd., Ste. 350
Durham, NC 27703 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Nancy PhelanCEO
Vuong TrieuChairman of the Board/Director
See More
Adhera Therapeutics, Inc. (formerly Marina Biotech, Inc.) is an emerging specialty pharmaceutical company focused on fixed dose combination (FDC) therapies in hypertension, with plans to expand the portfolio of drugs it commercializes to include other therapeutic areas. Adhera’s current product is .....See More See More

$USD, In whole numbers 2019201820172016201520142013
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture